Similar Articles
Urbach-Wiethe Disease and Intractable Epilepsy
Betül BAYKAN KURT, Ayşen GÖKYİĞİT, Oğuzhan ÇOBAN, Esen ÖZKAYA, Güzin ÖZARMAĞAN
Issue: 1995, Volume 1 - Issue 2
0
885
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Issue: 1995, Volume 1 - Issue 1
0
959
Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN
Issue: 1995, Volume 1 - Issue 1
0
932
Electroencephalographic Findings in Patients with COVID-19: A Single-center Experience
Nur Türkmen, Ahmet Buğrul, Bülent Oğuz Genç
DOI: 10.4274/tnd.2021.76329
Issue: 2021, Volume 27 - Supplement 1
0
1295
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
Issue: 2009, Volume 15 - Supplement 3
0
1057
Sudden unexpected death in epilepsy: A subject that spans from neurology to forensic sciences and genetics
Sude Danışman, Caner Beşkoç, Emrah Yücesan, Nihan Hande Akçakaya
DOI: 10.55697/tnd.2026.664
Issue: 2026, Volume 32 - Issue 1
1002
750
Longitudinal assessment of vestibular evoked myogenic potentials during one year of levetiracetam monotherapy in generalized epilepsy
İlknur Güçlü Altun, Rahşan İnan, Güray Koç, Banu Özen Barut
DOI: 10.55697/tnd.2026.602
Issue: 2026, Volume 32 - Issue 2
51
38


